Literature DB >> 19411018

Management issues in hematopoietic stem cell transplantation.

Robert David Rice1, Gay Bailey.   

Abstract

OBJECTIVES: To describe the leadership and management challenges of creating and maintaining a comprehensive hematopoietic stem cell transplant program. DATA SOURCES: Research studies, review articles, databases, and web sites.
CONCLUSION: Nurses at all levels of practice must conceptualize and execute expert specialized care through all phases of transplantation. Attention must be paid to specialized functions such as care coordination and case management, as well as scope of practice. Focus must be given to quality assessment and improvement. IMPLICATIONS FOR NURSING PRACTICE: As the field of transplant grows and evolves, expert nursing leadership will be required to manage the continuum of care as patients move between health care settings. The increased emphasis on outpatient care, cost containment, and consumer and regulatory demand for quality will continue to challenge nurse leaders to manage creative enterprises.

Entities:  

Mesh:

Year:  2009        PMID: 19411018     DOI: 10.1016/j.soncn.2009.03.009

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  3 in total

Review 1.  Interdisciplinary Educational Checklist for Allogeneic Stem Cell Transplant Patients.

Authors:  Jean A Ridgeway
Journal:  J Adv Pract Oncol       Date:  2018-09-01

Review 2.  Education of hematopoietic stem cell transplant caregivers in preparation for their role.

Authors:  Lynora J Metoyer
Journal:  J Adv Pract Oncol       Date:  2013-11

3.  "This Graft-vs.-Host Disease Determines My Life. That's It."-A Qualitative Analysis of the Experiences and Needs of Allogenic Hematopoietic Stem Cells Transplantation Survivors in Germany.

Authors:  Mira Parisek; Julika Loss; Ernst Holler; Anna Barata; Daniela Weber; Matthias Edinger; Daniel Wolff; Helene Schoemans; Anne Herrmann
Journal:  Front Public Health       Date:  2021-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.